SCHEMBL13311682

SCHEMBL13311682

CCOCCNC(=O)CCCN1C(=O)CC(SF)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
ALDH1A1 P00352 2/20 0.37
USP2 O75604 1/20 0.36
DRD2 P14416 1/20 0.35
LMNA P02545 1/20 0.35
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
FOLH1 Q04609 1/20 0.34
F2 P00734 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13339552 0.93 SMN1; SMN2 (0.38) SMN1; SMN2HPGDHTTALDH1A1USP2
SCHEMBL13311688 0.88 SMN1; SMN2 (0.35) SMN1; SMN2HPGDHTTALDH1A1USP2
SCHEMBL13339536 0.88 SMN1; SMN2 (0.46) SMN1; SMN2HPGDHTTALDH1A1DRD2
SCHEMBL277686 0.83 SMN1; SMN2 (0.39) SMN1; SMN2HPGDHTTALDH1A1USP2
SCHEMBL18264887 0.81 SMN1; SMN2 (0.37) SMN1; SMN2HPGDHTTALDH1A1USP2
SCHEMBL25100480 0.81 SMN1; SMN2 (0.45) SMN1; SMN2HPGDHTTALDH1A1USP2
SCHEMBL13339558 0.80 POLB (0.33) SMN1; SMN2HPGDHTTUSP2FOLH1
SCHEMBL14864100 0.80 HPGD (0.43) SMN1; SMN2HPGDHTTALDH1A1DRD2
SCHEMBL2607938 0.80 HTT (0.43) SMN1; SMN2HPGDHTTALDH1A1DRD2
SCHEMBL13167176 0.80 TSHR (0.36) HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137511-A1 POLYMER FACTOR IX MOIETY CONJUGATES NEKTAR THERAPEUTICS (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137511-A1 POLYMER FACTOR IX MOIETY CONJUGATES F9, F13A1, F8 SMN1; SMN2 2365/4885HPGD 1255/4885HTT 2131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.